NUVA Nuvasive Inc

Price (delayed)

$68.43

Market cap

$3.52B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.72

Enterprise value

$4.19B

Sector: Healthcare
Industry: Medical Devices

Highlights

The equity has grown by 2.2% from the previous quarter
NUVA's quick ratio is down by 28% year-on-year but it is up by 2.1% since the previous quarter
Nuvasive's net income has plunged by 157% YoY
NUVA's EPS has shrunk by 157% YoY

Key stats

What are the main financial stats of NUVA
Market
Shares outstanding
51.38M
Market cap
$3.52B
Enterprise value
$4.19B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.82
Price to sales (P/S)
3.35
EV/EBIT
182.74
EV/EBITDA
25.56
EV/Sales
3.99
Earnings
Revenue
$1.05B
EBIT
$22.92M
EBITDA
$163.86M
Free cash flow
$80.18M
Per share
EPS
-$0.72
Free cash flow per share
$1.56
Book value per share
$17.92
Revenue per share
$20.43
TBVPS
$38.53
Balance sheet
Total assets
$2.69B
Total liabilities
$1.77B
Debt
$1.53B
Equity
$918.92M
Working capital
$725.82M
Liquidity
Debt to equity
1.67
Current ratio
1.87
Quick ratio
1.48
Net debt/EBITDA
4.11
Margins
EBITDA margin
15.6%
Gross margin
69.4%
Net margin
-3.5%
Operating margin
3.6%
Efficiency
Return on assets
-1.5%
Return on equity
-4.1%
Return on invested capital
1.4%
Return on capital employed
1.2%
Return on sales
2.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NUVA stock price

How has the Nuvasive stock price performed over time
Intraday
-0.85%
1 week
0%
1 month
2.01%
1 year
16.3%
YTD
21.48%
QTD
4.38%

Financial performance

How have Nuvasive's revenue and profit performed over time
Revenue
$1.05B
Gross profit
$728.95M
Operating income
$38.3M
Net income
-$37.15M
Gross margin
69.4%
Net margin
-3.5%
The net margin has plunged by 163% YoY
Nuvasive's net income has plunged by 157% YoY
The company's operating income has shrunk by 69% YoY and by 36% QoQ
NUVA's operating margin has dropped by 66% year-on-year and by 36% since the previous quarter

Growth

What is Nuvasive's growth rate over time

Valuation

What is Nuvasive stock price valuation
P/E
N/A
P/B
3.82
P/S
3.35
EV/EBIT
182.74
EV/EBITDA
25.56
EV/Sales
3.99
NUVA's EPS has shrunk by 157% YoY
NUVA's price to book (P/B) is 28% more than its last 4 quarters average of 3.0
The equity has grown by 2.2% from the previous quarter
The price to sales (P/S) is 35% higher than the last 4 quarters average of 2.5 and 13% higher than the 5-year quarterly average of 3.0
Nuvasive's revenue has decreased by 10% YoY

Efficiency

How efficient is Nuvasive business performance
The company's return on equity has shrunk by 155% YoY
The return on assets has dropped by 142% year-on-year
The company's return on invested capital has shrunk by 84% YoY and by 48% QoQ
NUVA's ROS has shrunk by 78% YoY and by 46% QoQ

Dividends

What is NUVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUVA.

Financial health

How did Nuvasive financials performed over time
The total assets is 52% greater than the total liabilities
NUVA's total liabilities has soared by 83% year-on-year
NUVA's current ratio is down by 49% year-on-year
The debt is 67% more than the equity
The debt has soared by 118% YoY
NUVA's debt to equity has soared by 117% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.